tiprankstipranks
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
US Market
KPTI
Karyopharm Therapeutics
RESEARCH TOOLSreports
Want to see KPTI full AI Analyst Report?

Karyopharm Therapeutics (KPTI) Ratios

1,236 Followers

Karyopharm Therapeutics Ratios

KPTI's free cash flow for Q1 2026 was $0.96. For the 2026 fiscal year, KPTI's free cash flow was decreased by $ and operating cash flow was $-0.76. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.08 1.12 1.70 3.37 5.31
Quick Ratio
 1.05 1.08 1.64 3.32 5.25
Cash Ratio
 0.77 0.66 0.68 0.75 2.05
Solvency Ratio
 -0.49 -0.49 -0.22 -0.38 -0.44
Operating Cash Flow Ratio
 -0.50 -0.82 -1.38 -1.33 -2.27
Short-Term Operating Cash Flow Coverage
 -1.78 -3.59 -5.22 0.00 0.00
Net Current Asset Value
$ -270.73M$ -298.20M$ -193.94M$ -142.72M$ -24.67M
Leverage Ratios
Debt-to-Assets Ratio
 1.76 2.15 1.18 0.74 0.50
Debt-to-Equity Ratio
 -0.87 -0.80 -1.05 -1.30 -10.75
Debt-to-Capital Ratio
 -6.64 -3.94 22.87 4.34 1.10
Long-Term Debt-to-Capital Ratio
 -2.61 -2.37 -7.06 4.92 1.11
Financial Leverage Ratio
 -0.49 -0.37 -0.88 -1.77 -21.50
Debt Service Coverage Ratio
 -2.04 -2.24 -0.63 -4.98 -5.59
Interest Coverage Ratio
 -1.78 -1.98 -3.19 -5.44 -5.69
Debt to Market Cap
 2.90 2.82 2.27 1.73 0.61
Interest Debt Per Share
 12.64 25.56 28.55 26.38 37.39
Net Debt to EBITDA
 -0.85 -1.15 -3.42 -1.05 -0.32
Profitability Margins
Gross Profit Margin
96.03%95.93%95.86%96.62%96.68%
EBIT Margin
-109.20%-102.79%-26.81%-81.46%-89.08%
EBITDA Margin
-109.08%-102.59%-26.58%-81.09%-88.69%
Operating Profit Margin
-55.73%-62.10%-82.24%-88.71%-90.53%
Pretax Profit Margin
-129.01%-134.18%-52.58%-97.77%-105.00%
Net Profit Margin
-129.02%-134.21%-52.62%-97.99%-105.23%
Continuous Operations Profit Margin
-129.02%-134.21%-52.62%-97.99%-105.23%
Net Income Per EBT
100.00%100.02%100.07%100.23%100.22%
EBT Per EBIT
231.51%216.08%63.93%110.22%115.98%
Return on Assets (ROA)
-148.36%-180.82%-46.48%-59.52%-46.15%
Return on Equity (ROE)
73.11%66.92%41.08%105.06%992.38%
Return on Capital Employed (ROCE)
-596.61%-554.58%-165.54%-75.77%-48.66%
Return on Invested Capital (ROIC)
-177.79%-236.62%-123.11%-74.33%-48.18%
Return on Tangible Assets
-148.36%-180.82%-46.48%-59.52%-46.15%
Earnings Yield
-97.22%-243.58%-92.77%-144.78%-59.38%
Efficiency Ratios
Receivables Turnover
 6.47 5.58 4.72 5.42 3.34
Payables Turnover
 1.40 1.49 1.18 1.58 1.88
Inventory Turnover
 1.67 1.47 1.27 1.62 1.23
Fixed Asset Turnover
 33.58 31.40 23.11 29.91 21.29
Asset Turnover
 1.15 1.35 0.88 0.61 0.44
Working Capital Turnover Ratio
 15.02 3.88 1.27 0.65 0.65
Cash Conversion Cycle
 15.08 67.56 54.96 61.48 211.01
Days of Sales Outstanding
 56.41 65.41 77.32 67.39 109.42
Days of Inventory Outstanding
 218.76 247.75 287.95 224.75 295.75
Days of Payables Outstanding
 260.09 245.60 310.31 230.65 194.16
Operating Cycle
 275.17 313.17 365.27 292.14 405.17
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.69 -6.89 -15.69 -12.18 -27.40
Free Cash Flow Per Share
 -2.69 -6.89 -15.71 -12.18 -27.42
CapEx Per Share
 0.00 0.00 0.02 0.00 0.02
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -897.79 0.00 -1.27K
Capital Expenditure Coverage Ratio
 0.00 0.00 -897.79 0.00 -1.27K
Operating Cash Flow Coverage Ratio
 -0.26 -0.32 -0.66 -0.52 -0.84
Operating Cash Flow to Sales Ratio
 -0.39 -0.52 -0.88 -0.63 -0.95
Free Cash Flow Yield
-76.01%-93.65%-154.93%-93.81%-53.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.03 -0.41 -1.08 -0.69 -1.68
Price-to-Sales (P/S) Ratio
 0.51 0.55 0.57 0.68 1.77
Price-to-Book (P/B) Ratio
 -0.75 -0.27 -0.44 -0.73 -16.71
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.32 -1.07 -0.65 -1.07 -1.86
Price-to-Operating Cash Flow Ratio
 -3.39 -1.07 -0.65 -1.07 -1.86
Price-to-Earnings Growth (PEG) Ratio
 0.01 >-0.01 0.02 0.02 -0.08
Price-to-Fair Value
 -0.75 -0.27 -0.44 -0.73 -16.71
Enterprise Value Multiple
 -1.32 -1.69 -5.55 -1.89 -2.31
Enterprise Value
 217.80M 253.55M 214.43M 223.62M 322.25M
EV to EBITDA
 -1.32 -1.69 -5.55 -1.89 -2.31
EV to Sales
 1.44 1.74 1.48 1.53 2.05
EV to Free Cash Flow
 -3.68 -3.36 -1.68 -2.41 -2.15
EV to Operating Cash Flow
 -3.68 -3.36 -1.68 -2.41 -2.15
Tangible Book Value Per Share
 -12.07 -26.79 -22.90 -17.89 -3.05
Shareholders’ Equity Per Share
 -12.07 -26.79 -22.90 -17.89 -3.05
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 6.86 13.36 17.88 19.18 28.78
Net Income Per Share
 -8.86 -17.93 -9.41 -18.79 -30.28
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.18 1.31 1.96 1.20 1.18
Research & Development to Revenue
 0.83 0.86 0.99 0.95 0.95
SG&A to Revenue
 0.69 0.72 0.79 0.90 0.93
Stock-Based Compensation to Revenue
 0.07 0.10 0.13 0.15 0.23
Income Quality
 0.30 0.38 1.67 0.65 0.90
Currency in USD